Package 50242-077-01

{"route": ["SUBCUTANEOUS"], "spl_id": "6f91c20d-3654-4d9f-bfda-557364b1e7ea", "openfda": {"nui": ["N0000175531", "M0009499", "N0000175661", "N0000020008"], "unii": ["743QUY4VD8", "P188ANX8CK"], "rxcui": ["2119714", "2119719"], "spl_set_id": ["ebf30894-41cf-480c-8bc3-56f592a13813"], "pharm_class_cs": ["Glycoside Hydrolases [CS]"], "pharm_class_epc": ["Endoglycosidase [EPC]", "HER2/neu Receptor Antagonist [EPC]"], "pharm_class_moa": ["HER2/Neu/cerbB2 Antagonists [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (50242-077-01)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "50242-077-01", "marketing_start_date": "20190228"}], "brand_name": "Herceptin Hylecta", "product_id": "50242-077_6f91c20d-3654-4d9f-bfda-557364b1e7ea", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Endoglycosidase [EPC]", "Glycoside Hydrolases [CS]", "HER2/Neu/cerbB2 Antagonists [MoA]", "HER2/neu Receptor Antagonist [EPC]"], "product_ndc": "50242-077", "generic_name": "Trastuzumab and hyaluronidase-oysk", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Herceptin Hylecta", "active_ingredients": [{"name": "HYALURONIDASE (HUMAN RECOMBINANT)", "strength": "10000 U/5mL"}, {"name": "TRASTUZUMAB", "strength": "600 mg/5mL"}], "application_number": "BLA761106", "marketing_category": "BLA", "marketing_start_date": "20190228", "listing_expiration_date": "20261231"}